Cogent Biosciences, Inc. (COGT)
32.58
-0.34
(-1.05%)
USD |
NASDAQ |
May 21, 16:00
32.45
-0.13
(-0.40%)
After-Hours: 19:59
Cogent Biosciences Research and Development Expense (TTM) : 277.48M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Syndax Pharmaceuticals, Inc. | 255.98M |
| Vera Therapeutics, Inc. | 259.47M |
| Nuvalent, Inc. | 316.16M |
| Insmed, Inc. | 828.00M |
| Mirum Pharmaceuticals, Inc. | 237.68M |